Lilly's selective amylin agonist, eloralintide, demonstrated meaningful weight loss and favorable tolerability in a Phase 2 study of adults with obesity or overweight
By Naomi Kresge | Bloomberg Eli Lilly & Co.s obesity drug Zepbound helped people trim about two inches more off their waists than Novo Nordisk A/Ss Wegovy in the first head-to-head study of the rival medicines
(50 mg IM twice weekly slowed functional decline by ~43% in early-stage ALS.) Clinical safety of ultra-high-dose methylcobalamin in patients with amyotrophic lateral sclerosis: Open-label extension (long-term safety data)
Its a way of eating that focuses on: Fruits and vegetables Beans and cereals Wholegrain bread and pasta Brown rice Fish and white meat Low-fat dairy Olive oil Nuts Red meat, sweets, desserts and alcohol are consumed occasionally and in smaller quantities
8.1.1 Genomic and system-level approaches In the last two to three decades, NGS technologies have generated large amounts of omics data (genomics, transcriptomics, proteomics, epigenomics, and metabolomics), post-translational modification data (phosphorylation, SUMOylation, ubiquitinylation, etc.), single-cell, ATAC-Seq data and more, which provide a powerful lens for deciphering the molecular landscape of breast cancer (269)
Found on the internet at 6
